• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dapsone, 2 birds with 1 stone: A response to "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients".

作者信息

Kneiber Diana, Kowalski Eric H, Amber Kyle T

机构信息

Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois.

Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois.

出版信息

J Am Acad Dermatol. 2021 Dec;85(6):e369. doi: 10.1016/j.jaad.2019.03.093. Epub 2019 Apr 19.

DOI:10.1016/j.jaad.2019.03.093
PMID:31009669
Abstract
摘要

相似文献

1
Dapsone, 2 birds with 1 stone: A response to "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients".氨苯砜，一石二鸟：对“氨苯砜在免疫性大疱性疾病患者预防卡氏肺孢子虫肺炎方面优于复方新诺明”的回应
J Am Acad Dermatol. 2021 Dec;85(6):e369. doi: 10.1016/j.jaad.2019.03.093. Epub 2019 Apr 19.
2
Response: Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients.
J Am Acad Dermatol. 2021 Dec;85(6):e371-e372. doi: 10.1016/j.jaad.2019.04.039. Epub 2019 Apr 20.
3
Advantages of dapsone over trimethoprim/sulfamethoxazole for Pneumocystis pneumonia prophylaxis in patients with immunobullous disease.
J Am Acad Dermatol. 2021 Dec;85(6):e325. doi: 10.1016/j.jaad.2019.01.091. Epub 2019 Feb 27.
4
Prophylaxis of pneumocystis pneumonia and toxoplasmosis.
Ann Intern Med. 1996 Jun 15;124(12):1096. doi: 10.7326/0003-4819-124-12-199606150-00017.
5
Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.低剂量氨苯砜、复方新诺明与卡氏肺孢子虫病的一级预防及生存情况
AIDS. 1996 Aug;10(9):1046-7. doi: 10.1097/00002030-199610090-00020.
6
Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎预防失败的原因。
AIDS. 1999 May 28;13(8):991-2. doi: 10.1097/00002030-199905280-00017.
7
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.对人类免疫缺陷病毒（HIV）感染患者预防卡氏肺孢子虫肺炎和弓形虫性脑炎治疗方法的荟萃分析。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.
8
Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.氨苯砜用于对甲氧苄啶/磺胺甲恶唑过敏的人类免疫缺陷病毒感染患者预防卡氏肺孢子虫肺炎的安全性。
Am J Med. 1996 Jun;100(6):611-6. doi: 10.1016/s0002-9343(96)00008-3.
9
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.艾滋病患者轻度至中度卡氏肺孢子虫肺炎三种治疗方案的比较。口服甲氧苄啶-磺胺甲恶唑、氨苯砜-甲氧苄啶和克林霉素-伯氨喹的双盲、随机试验。美国国立过敏与传染病研究所艾滋病临床试验组108研究小组。
Ann Intern Med. 1996 May 1;124(9):792-802. doi: 10.7326/0003-4819-124-9-199605010-00003.
10
High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.接受氨苯砜预防治疗的异基因血液和骨髓移植受者中卡氏肺孢子虫肺炎的高发病率。
Clin Infect Dis. 1999 Dec;29(6):1467-71. doi: 10.1086/313509.

引用本文的文献

1
Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications.叶酸拮抗剂：抗菌和免疫调节机制与应用。
Int J Mol Sci. 2019 Oct 9;20(20):4996. doi: 10.3390/ijms20204996.